2014: The Year of Personalized Medicine

Investment blog Motley Fool recently ran an entry entitled, “2014: The Year of Personalized Medicine” describing innovations in personalized medicine, specifically next generation sequencing for cancer patients. Laboratories, including PGXL, are investing in technology that will will personalize the treatment of cancer

The development will revolutionize the way we think about drug development, and suggests that innovation in the industry is still chugging along. High throughput gene sequencing could bring population studies of risk factors for cancer, Alzheimer’s, diabetes, and more to the forefront of research.

PGXL’s NGS is installed and going through validation. Stay tuned…

by Content_Management
This entry was posted in Interesting Reads. Bookmark the permalink.

Comments are closed.